Washington Roundup: CDRH: MDUFMA 1Q05 results include increased workload March 2, 2005 By Christopher Delporte
Diabetes Drug Glumetza Gets Approvable Letter From FDA March 2, 2005 By Aaron Lorenzo The FDA issued an approvable letter for Glumetza, a once-daily, extended-release version of the diabetes drug metformin, driving up Depomed Inc.'s stock value by 11 percent. (BioWorld Today)Read More
RSS